References
- Dupuis L, Chan H SL, Lacey C, McBride J. The management of chemotherapy-induced nausea and vomiting in children. Can J Hasp Pharm. 1986; 39: 38–39
- Terrin B N, McWilliams N B, Maurer H M. Side effects of metoclopramide as an anti-emetic in childhood cancer chemotherapy. J Pediatr. 1984; 104: 138–140
- Zeltzer L, Le Baron S, Zeltzer P M. Paradoxical effect of prophylactic phenothiazine anti-emetics in children receiving chemotherapy. J Clin Oncol. 1984; 2: 930–936
- Hewitt M, McQuade B, Stevens R. The efficacy and safety of ondansetron in the prophylaxis of cancer chemotherapy-induced nausea and vomiting in children. Clin Oncol. 1993; 5: 11–14
- Stevens R F. The role of ondansetron in paediatric patients: A review of three studies. Eur J Cancer 1991; 27: S20–S22, Suppl 1
- Pinkerton C R, William D, Wootton C, Meller S T, McElwain T J. 5-HTs antagonist ondansetron-an effective outpatient antiemetic in cancer treatment. Arch Dis Child. 1990; 65: 822–825
- Carson J A, Gormican A. Taste acuity and food attitudes of selected patients with cancer. J Am Diet Assoc. 1977; 70: 361–365
- Mulder N H, Smit J M, Kreumer W M. Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma. Oncology 1983; 40: 36–38
- Bryson J C. Clinical safety of ondansetron. Semin Oncol. 1992; 19: 26–32
- McQueen K D, Milton J D. Multicenter postmarketing surveillance of ondansetron therapy in pediatric patients. Ann Pharmacother. 1994; 28: 85–92